The acidic microenvironment as a possible niche of dormant tumor cells-Reference-Cited by-同舟云学术

The acidic microenvironment as a possible niche of dormant tumor cells

Published:2017-03-22 Issue:15 Volume:74 Page:2761-2771
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Peppicelli Silvia,Andreucci Elena,Ruzzolini Jessica,Laurenzana Anna,Margheri Francesca,Fibbi Gabriella,Del Rosso Mario,Bianchini Francesca,Calorini Lido

Funder

Istituto Toscano Tumori

Ente Cassa di Risparmio di Firenze

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s00018-017-2496-y/fulltext.html

Reference115 articles.

1. Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834–846

2. Wheelock EF, Weinhold KJ, Levich J (1981) The tumor dormant state. Adv Cancer Res 34:107–140

3. Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153

4. Naumov GN, Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J, Almog N (2006) A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Ins 98:316–325

5. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor;International Journal of Pharmaceutics;2024-05

2. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies;Journal of Drug Targeting;2024-02

3. Metabolic challengers selecting tumor-persistent cells;Trends in Endocrinology & Metabolism;2023-12

4. ASIC1a contributes to the epithelial–mesenchymal transformation of breast cancer by activating the Ca²⁺/β‐catenin pathway;Environmental Toxicology;2023-11-22

5. Improving targeted small molecule drugs to overcome chemotherapy resistance;Cancer Reports;2023-11-22